July 22nd 2025, 8:00pm
A system that alerts doctors when high-risk cancer patients are admitted helped reduce hospital readmissions and shorten hospital stays in a recent study.
July 22nd 2025, 7:07pm
Samantha Bianzon explained what biology-guided radiation therapy for cancer is, as well as highlighted how it may differ from the more traditional types of radiation.
July 22nd 2025, 5:00pm
Living with Lynch syndrome, nature’s quiet resilience teaches me to accept change, find calm, and stay rooted through life’s unexpected twists and storms.
July 22nd 2025, 4:00pm
Data from the KEYNOTE-B61 trial show tumor shrinkage in different types of kidney cancer, including papillary and chromophobe subtypes.
July 22nd 2025, 3:00pm
Tagrisso with chemo significantly improved survival and progression-free outcomes versus Tagrisso alone in newly diagnosed advanced EGFR-mutated lung cancer.
July 22nd 2025, 1:19pm
Disparities in cancer care can often lead to delays, disruptions, and barriers to timely treatment, leading to an unmet need in the community treatment space.
July 21st 2025, 9:00pm
Keeping my part-time teaching job during breast cancer treatment gave me purpose, connection and strength — and it helped me rediscover my voice as a writer.
July 21st 2025, 8:00pm
Q-TWiST may help patients with advanced kidney cancer and their doctors weigh treatment options by focusing on quality of life, not just disease control.
July 21st 2025, 7:00pm
Stereotactic body radiotherapy costs less and has shown better safety compared with immunotherapy and tyrosine kinase inhibitors in patients kidney cancer.
July 21st 2025, 6:00pm
Treatment with Zusduri had a median duration of response of 3.5 years and event-free survival of two years in low-grade intermediate-risk bladder cancer.
Understanding Your Diagnosis of Bile Duct Cancer
Understanding Your Stage 2 Uterine (Endometrial) Cancer
Top Blood Cancer Stories from October: Key Updates for Patients
Expert Explains Need for Better Outcomes in Resectable Lung Cancer